Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ORPEA Regulatory Filings 2023

May 17, 2023

1578_rns_2023-05-17_73ede15a-f420-4cf5-90f0-9316218a8da4.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

Puteaux (France), 17 May 2023 (6:00 pm CEST)

REDUCTION OF THE RESOURCES ALLOCATED TO THE LIQUIDITY CONTRACT ENTERED WITH NATIXIS ODDO BHF

ORPEA (ISIN code: FR0000184798) announces having concluded today a first amendment to the liquidity and market surveillance contract entered into on 30 November 2022 with Natixis ODDO BHF SCA. This amendment complies with the Autorité des Marchés Financiers (AMF) decision no. 2021-01 dated 22 June 2021 related to the establishing of liquidity contracts on shares as accepted market practice.

Within the limits of the AMF decision no. 2021-01 dated 22 June 2021, ORPEA decides to reduce the resources allocated to the liquidity contract by twenty-one thousand one hundred and eighty-six (21,186) ORPEA shares, in order to give ORPEA shares to its employees pursuant to a free shares plan dated 1 February 2020.

After reduction, the resources allocated will be:

  • 46,814 ORPEA shares
  • 415,560 euros

About ORPEA

ORPEA is a leading global player, expert in providing care for all types of frailty. The Group operates in 22 countries and covers three core businesses: care for the elderly (nursing homes, assisted living facilities, homecare and services), post-acute and rehabilitation care and mental health care (specialized clinics). It has more than 76,000 employees and welcomes more than 267,000 patients and residents each year.

https://www.orpea-group.com/en

ORPEA is listed on Euronext Paris (ISIN: FR0000184798) and is a member of the SBF 120, MSCI Small Cap Europe and CAC Mid 60 indices.

Investor Relations Investor Relations Press Relations
ORPEA NewCap ORPEA
Benoit Lesieur Dusan Oresansky Isabelle Herrier-Naufle
Investor Relations Director Tel: 01 44 71 94 94 Press Relations Director
[email protected] [email protected] Tel: 07 70 29 53 74

Toll-free number for shareholders :

+33(0) 805 480 480

[email protected] Image 7 Charlotte Le Barbier Tel: 06 78 37 27 60 [email protected] Laurence Heilbronn

Tel: 06 89 87 61 37 [email protected]

2 | 2